Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1973 1
1974 1
1975 1
1979 1
1981 1
1983 2
1984 1
1986 1
1987 1
1989 2
1990 4
1991 3
1992 5
1993 6
1994 5
1995 4
1996 13
1997 6
1998 12
1999 8
2000 13
2001 20
2002 45
2003 56
2004 87
2005 94
2006 134
2007 139
2008 175
2009 212
2010 300
2011 366
2012 403
2013 445
2014 510
2015 544
2016 580
2017 596
2018 607
2019 659
2020 699
2021 738
2022 731
2023 584
2024 503

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,186 results

Results by year

Filters applied: . Clear all
Page 1
Sleep and Obesity.
Lee JH, Cho J. Lee JH, et al. Sleep Med Clin. 2022 Mar;17(1):111-116. doi: 10.1016/j.jsmc.2021.10.009. Epub 2022 Jan 3. Sleep Med Clin. 2022. PMID: 35216758 Review.
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
3D bioprinted silk fibroin hydrogels for tissue engineering.
Kim SH, Hong H, Ajiteru O, Sultan MT, Lee YJ, Lee JS, Lee OJ, Lee H, Park HS, Choi KY, Lee JS, Ju HW, Hong IS, Park CH. Kim SH, et al. Nat Protoc. 2021 Dec;16(12):5484-5532. doi: 10.1038/s41596-021-00622-1. Epub 2021 Oct 29. Nat Protoc. 2021. PMID: 34716451 Review.
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.
Mak LY, Gane E, Schwabe C, Yoon KT, Heo J, Scott R, Lee JH, Lee JI, Kweon YO, Weltman M, Harrison SA, Neuschwander-Tetri BA, Cusi K, Loomba R, Given BD, Christianson DR, Garcia-Medel E, Yi M, Hamilton J, Yuen MF. Mak LY, et al. Among authors: lee ji. J Hepatol. 2023 Apr;78(4):684-692. doi: 10.1016/j.jhep.2022.11.025. Epub 2022 Dec 10. J Hepatol. 2023. PMID: 36513186 Clinical Trial.
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, Jeon D, Lee T, Lee JY, Park JS, Lee SH, Kang YA, Lee JK, Kwak N, Ahn JH, Shim TS, Kim SY, Kim S, Kim K, Seok KH, Yoon S, Kim YR, Kim J, Yim D, Hahn S, Cho SN, Yim JJ; MDR-END investigators. Mok J, et al. Lancet. 2022 Oct 29;400(10362):1522-1530. doi: 10.1016/S0140-6736(22)01883-9. Lancet. 2022. PMID: 36522208 Clinical Trial.
8,186 results